Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Jeanene J Fogli"'
Autor:
Edward Saltzman, Jeanene J. Fogli-Cawley, Lisa M. Troy, Paul F. Jacques, Marjorie L. McCullough, Johanna T. Dwyer
Publikováno v:
The Journal of Nutrition. 136:2908-2915
The sixth edition of the Dietary Guidelines for Americans (DGA) was released in January 2005, with revised healthy eating recommendations for all adult Americans. We developed the 2005 Dietary Guidelines Adherence Index (DGAI) as a measure of adheren
Autor:
Bobbie Paull-Forney, Jeanene J Fogli, James Early, Elizabeth Ablah, Linda D Gotthelf, Justin B Moore, Frank Dong
Publikováno v:
Journal of Community Medicine & Health Education. 3
Background: In light of recent Centers for Medicare and Medicaid Services (CMS) recommendations on behavioral therapy for obesity, it is important to assess the outcomes of physician-directed low-calorie diet (LCD) interventions on metabolic risk fac
Autor:
James B. Meigs, Jeanene J. Fogli-Cawley, Edward Saltzman, Marjorie L. McCullough, Paul F. Jacques, Lisa M. Troy, Johanna T. Dwyer
Publikováno v:
The American journal of clinical nutrition. 86(4)
Background: The 2005 Dietary Guidelines for Americans Index (DGAI) was created to assess adherence to the dietary recommendations of the 2005 Dietary Guidelines for Americans (DGA) in relation to chronic disease risk. Objective: The objective was to
Autor:
Jeanene J. Fogli-Cawley, Marjorie L. McCullough, Edward Saltzman, Paul F. Jacques, Johanna T. Dwyer, James B. Meigs, Lisa M. Troy
Publikováno v:
Diabetes care. 30(4)
OBJECTIVE—The aim of this study was to examine the relationship between a diet consistent with the 2005 Dietary Guidelines for Americans (DGA), as assessed by the 2005 Dietary Guidelines for Americans Adherence Index (DGAI), and measures of insulin
Autor:
Jeanene J. Fogli
Publikováno v:
Obesity Research. 13:1134-1134
Autor:
Desai NR; Internal Medicine, Center for Outcomes Research and Evaluation, Yale University, New Haven, Connecticut, United States of America., Rowan CG; Pharmacoepidemiology, COHRDATA, Santa Monica, California, United States of America., Alvarez PJ; Managed Care Health Outcomes, Relypsa, Inc., a Vifor Pharma Company, Redwood City, California, United States of America., Fogli J; Medical Affairs, Relypsa, Inc., a Vifor Pharma Company, Redwood City, California, United States of America., Toto RD; Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas, United States of America.
Publikováno v:
PloS one [PLoS One] 2020 Jan 07; Vol. 15 (1), pp. e0226844. Date of Electronic Publication: 2020 Jan 07 (Print Publication: 2020).
Autor:
Desai NR; Assistant Professor of Medicine, Yale School of Medicine, New Haven, CT., Reed P; Senior Director, Outcomes Research and Analysis, Intelligent Health Analytics, Tallahassee, FL., Alvarez PJ; Senior Director, Managed Care Health Outcomes, Relypsa, a Vifor Pharma Group Company, Redwood City, CA., Fogli J; Executive Director, Medical Affairs, Relypsa, a Vifor Pharma Group Company, Redwood City, CA., Woods SD; Senior Director, Managed Care Health Outcomes, Relypsa, a Vifor Pharma Group Company, Redwood City, CA., Owens MK; President and Chief Executive Officer, Intelligent Health Analytics.
Publikováno v:
American health & drug benefits [Am Health Drug Benefits] 2019 Nov; Vol. 12 (7), pp. 352-361.
Autor:
Bushinsky DA; Division of Nephrology, Department of Medicine, University of Rochester School of Medicine and Dentistry, Rochester, New York., Spiegel DM; Clinical Development., Yuan J; Biometrics., Warren S; Clinical Operations., Fogli J; Medical Affairs, Relypsa, Inc., a Vifor Pharma Group Company; and., Pergola PE; Renal Associates, PA, San Antonio, Texas.
Publikováno v:
Clinical journal of the American Society of Nephrology : CJASN [Clin J Am Soc Nephrol] 2019 Jan 07; Vol. 14 (1), pp. 103-110. Date of Electronic Publication: 2018 Oct 31.
Autor:
Kovesdy CP; Department of Medicine, Division of Nephrology, University of Tennessee Health Science Center, Memphis, Tennessee, USA., Rowan CG; Department of Pharmacoepidemiology, COHRDATA, Santa Monica, California, USA., Conrad A; Medical Affairs, Relypsa Inc., a Vifor Pharma Group Company, Redwood City, California, USA., Spiegel DM; Clinical Development, Relypsa Inc., a Vifor Pharma Group Company, Redwood City, California, USA., Fogli J; Medical Affairs, Relypsa Inc., a Vifor Pharma Group Company, Redwood City, California, USA., Oestreicher N; Department of Global Medical and Scientific Affairs, Halozyme, Inc., San Diego, California, USA.; Department of Clinical Pharmacy, University of California, San Francisco, San Francisco, California, USA., Connaire JJ; Nephrology Services, Davita Clinical Research, Minneapolis, Minnesota, USA., Winkelmayer WC; Department of Medicine, Section of Nephrology, Baylor College of Medicine, Houston, Texas, USA.
Publikováno v:
Kidney international reports [Kidney Int Rep] 2018 Oct 29; Vol. 4 (2), pp. 301-309. Date of Electronic Publication: 2018 Oct 29 (Print Publication: 2019).
Autor:
Bridgeman M, Prete D, Rolston N, Abazia D, Sturgill M, Finn L, Summers D, Marvanova M, Henkel P, Thompson J, Dewey M, Friesner D, Marvanova M, Alessi C, Cuellar L, Yamagishi L, O'Neil C, Erickson O, Mazzei K, Kamal K, Early N, Bainter B, Hanson L, Schmitz E, Loomis A, Norberto M, Hume A, Meyer M, Batra R, Likar D, Enguidanos S, Liu C, Kotansky B, Fisher A, Ruby CM, Pruskowski J, Karim SNA, Yong BSW, Alessi C, Cuellar L, Slattum P, Crouse E, Delafuente J, Donohoe K, Ogbonna K, Peron E, Powers K, Price E, Zimmerman K, Rahim S, Gendron T, Slattum P, Donohoe K, Cho C, Zimmerman K, Crouse E, Peron E, Powers K, Price E, Slattum P, Donohoe K, Elliott L, Minter C, Morin M, Marshall L, Stevens G, Cordaro C, Hill M, Nagy K, Kroustos KR, Sobota KF, Mahan R, Bailey T, Ioannou K, Mansour D, Thompson T, Chatellier K, Schwenk A, Ruby C, Chen TS, Li S, James M, Spilios M, Leschak A, Levine A, Forgette S, Oluigbo N, Szollosi D, Avalime D, Weaver SB, Maneno M, Ettienne E, Yi JY, Hart L, Gray S, Ozalas S, Miller K, Dave R, Bork J, Emmelhainz J, Adams K, Postolski J, Willoughby M, Feldman E, Braham K, Miller C, Barbagallo D, Seabury R, Noviasky J, Alessi C, Cuellar L, Dabhi J, Bartlett D, Le T, Simoni-Wastila L, Kuzucan A, Simoni-Wastila L, Le T, Park S, Simoni-Wastila L, Le T, Park S, Choi M, Simoni-Wastila L, Park S, Le T, Choi M, Simoni-Wastila L, Khokhar B, Choi M, Le T, Simoni-Wastila L, Brody P, Hejna M, Mason J, Graham M, Micceri J, Lypska R, Quinn B, Wilson H, Wahler R, Aloyo M, Tomm V, Hill A, Obringer A, Butterfoss K, Blak J, Balcer R, Boza J, Foster A, Shafique E, Kleven C, Wigle P, Brown B, Alessi C, Cuellar L, Meyer K, Mobley-Bukstein W, Singh H, Perez E, Mira AE, Kuehner W, Czechowski L, Cook H, Brandt N, Parson J, Fornaro R, Brandt N, Claeys K, Zarowitz B, Mansour D, McFadden C, Simpkins S, Ojowa F, Klutts A, Holmes S, Smith E, Cornman JR, Doran K, Resnick B, Brandt N, Umeozulu C, Williams A, Brandt N, Hennawi G, Thomas D, Gerber DK, Meyer K, Sharma K, Cooke C, Howard A, Chater R, Vogler A, Brandt N, Kennett-Hayes K, Elliott L, Engelbert J, Hargrave E, Bambico C, Patel K, Warriner C, Slattum P, Desai NR, Rowan CG, Alvarez P, Fogli J, Toto RD, Desai NR, Alvarez P, Fogli J, Reed P, Owens MK, Greden JF, Rothschild AJ, Zandy S, Thase M, Dunlop BW, DeBattista C, Conway CR, Forester BP, Mondimore FM, Shelton RC, Li J, Gilbert A, Burns L, Jablonski M, Dechairo B, Parikh S, Donohue J, Feldman G, Sethi S, Barnes C, Pendyala S, Bourdet D, Ferguson G, Barnes C, Pendyala S, Crater G, Fogli J, Mayo M, Gross C, Miyawa J, Ono R, Woods S, Garza D, Panov N, Fogli J, Moran E, Sabesan V, Wertman J, Ngim K
Publikováno v:
The Consultant pharmacist : the journal of the American Society of Consultant Pharmacists [Consult Pharm] 2017 Oct 01; Vol. 33 (10), pp. 572-608.